Riskpilot← Back to searchSign inGet full accessGlänta Group AB
ABActiveOrg 5593077166Drottensgatan 4Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
+23% vs 2023
Equity ratio
93.5%
Financial strength
Net profit 2024
SEK -1,1M
+20% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,1M | +23% |
| Net profit | SEK -1,1M | +20% |
| Total assets | SEK 4,3M | -13% |
| Equity | SEK 4M | -13% |
| Employees | 0 | — |
Legal name
Glänta Group AB
Org number
5593077166
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
18 mars 2021
Share capital
SEK 66 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva teknikutveckling, produktutveckling, marknadsföring och försäljning inom området livsvetenskap samt därmed förenlig verksamhet.
Address
Drottensgatan 4
Email
johan@jombo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −253 | −1 442 | −1 108 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −253 | −1 442 | −1 108 |
| Net financials | −5 | 59 | — |
| Profit before tax | −258 | −1 383 | −1 108 |
| Tax | −0 | −0 | −0 |
| Net profit | −258 | −1 383 | −1 108 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 6 125 | 4 894 | 4 280 |
| Equity | 5 992 | 4 609 | 4 000 |
| Long-term debt | 0 | 0 | 111 |
| Short-term debt | 132 | 285 | 169 |
| Total debt | 132 | 285 | 280 |
EBITDA margin
-110800000.0%
This company
15.8%
Market median
-701265923% vs market
20222024
Equity ratio
93.5%
This company
38.2%
Market median
+145% vs market
20222024
Return on equity
-27.7%
This company
18.4%
Market median
-251% vs market
20222024
Net profit margin
-110800000.0%
This company
8.1%
Market median
-1367901335% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RM Chief Auditor | Chief Auditor | 2022 | — | — |
BI Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Compail AB | Company | 75.0% | 75.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Compail AB
Glänta Group AB Board members of Glänta Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Martin Bendz | Chief Auditor | 0 companies |
| Bogdan Ionut Tudosoiu | Chief Executive Officer | 0 companies |
| Agnes Cecilia Möllerström | Deputy Board Member | 0 companies |
| Anette Maria Pavlovic | Board of Directors | 0 companies |
| Lars Johan Möllerström | Chairman | 0 companies |
| Lars Magnus Britse | Board of Directors | 0 companies |